V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230002195 | 230008314 | 1.5 | 59 | null | 2019-05-11 | 2020-01-06 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100225814 |
| 230002196 | 230008315 | null | null | null | 2021-06-09 | 2021-09-21 | ETOPOSIDE | 02 | null | PEMBROLIZUMAB | 100917034 |
| 230002199 | 230008316 | 1.59 | 73 | null | 2022-02-09 | 2022-02-09 | Liposomal Doxorubicin 40mg/m2 | 02 | null | LIPOSOMAL DOXORUBICIN | 100988405 |
| 230002205 | 230008317 | null | null | Adjuvant (A) | 2019-10-19 | 2019-11-10 | CARBOPLATIN | 02 | N | CARBOPLATIN | 101863147 |
| 230002207 | 230008318 | 1.63 | 71.3 | Palliative (P) | 2020-11-24 | 2020-12-13 | null | null | N | CARBOPLATIN + GEMCITABINE | 100544319 |
| 230002208 | 230008319 | 1.62 | 92.6 | Palliative (P) | 2022-04-06 | 2022-04-14 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100417143 |
| 230002212 | 230008321 | 1.58 | 97 | Palliative (P) | null | 2020-11-23 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 101395669 |
| 230002213 | 230008322 | 1.59 | 60.2 | null | 2021-03-26 | 2021-03-26 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100396177 |
| 230002215 | 230008323 | 1.73 | 95.2 | Palliative (P) | 2020-09-06 | 2021-02-02 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100115300 |
| 230002219 | 230008325 | 1.59 | 57.6 | null | 2021-01-16 | 2021-02-06 | null | N | null | CARBOPLATIN + GEMCITABINE | 100788570 |
| 230002225 | 230008327 | 1.66 | 104 | Palliative (P) | null | 2018-09-05 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101600305 |
| 230002226 | 230008328 | null | null | Palliative (P) | 2021-10-04 | 2021-10-07 | null | null | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100126004 |
| 230002233 | 230008329 | 1.59 | 102.95 | null | 2020-07-16 | 2021-05-17 | PACLITAXEL | 02 | null | PACLITAXEL | 101079093 |
| 230002234 | 230008330 | null | null | null | 2020-05-13 | 2020-05-13 | Carboplatin AUC 2 - 5 | 02 | null | TRIAL UNSPECIFIED | 101273499 |
| 230002236 | 230008331 | 1.67 | 68.4 | null | null | 2021-01-12 | Niraparib | 02 | null | NIRAPARIB | 100590159 |
| 230002237 | 230008332 | 1.57 | 106.2 | Palliative (P) | null | 2019-07-19 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100107581 |
| 230002240 | 230008333 | null | null | null | 2017-09-05 | 2021-10-09 | Niraparib | 02 | null | NIRAPARIB | 101504664 |
| 230002247 | 230008335 | null | null | null | 2020-08-16 | 2020-09-22 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100327150 |
| 230002249 | 230008337 | 1.65 | 66.4 | null | null | 2022-05-29 | Cisplatin | 02 | null | TRIAL UNSPECIFIED | 100444839 |
| 230002252 | 230008338 | 1.62 | 61.9 | Palliative (P) | null | 2020-06-20 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101589084 |
| 230002257 | 230008340 | 1.6 | 61 | null | 2021-05-08 | 2021-05-16 | null | null | null | BEVACIZUMAB | 100731899 |
| 230002258 | 230008341 | 1.62 | 86.4 | Curative (C) | null | 2020-04-08 | null | null | N | CARBOPLATIN + DOCETAXEL | 100778972 |
| 230002261 | 230008344 | 1.53 | 104.4 | Adjuvant (A) | 2016-09-11 | 2016-11-01 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | PEMBROLIZUMAB | 101114523 |
| 230002264 | 230008347 | null | null | Adjuvant (A) | 2019-12-21 | 2020-01-01 | Olaparib | 02 | N | OLAPARIB | 101792400 |
| 230002266 | 230008348 | null | null | Palliative (P) | 2020-04-12 | 2020-09-02 | null | null | N | PACLITAXEL | 101259615 |
| 230002269 | 230008349 | 1.61 | 36.4 | Neo-adjuvant (N) | 2021-11-16 | 2021-12-01 | Bevacizumab 7.5mg/kg | 02 | N | BEVACIZUMAB | 100652381 |
| 230002274 | 230008351 | 1.63 | 64.8 | Neo-adjuvant (N) | 2019-08-18 | 2019-09-01 | Niraparib | 02 | N | NIRAPARIB | 100560810 |
| 230002277 | 230008352 | 1.67 | 78.3 | null | 2019-04-29 | 2019-06-29 | null | 01 | null | PACLITAXEL | 101787983 |
| 230002281 | 230008353 | null | null | null | 2020-11-11 | 2020-11-18 | Olaparib | 02 | null | OLAPARIB | 100728949 |
| 230002282 | 230008354 | null | null | null | 2022-04-24 | 2022-05-28 | null | N | null | NIRAPARIB | 100297974 |
| 230002284 | 230008355 | null | null | null | 2021-09-24 | 2022-01-04 | Niraparib | 02 | null | NIRAPARIB | 100866680 |
| 230002286 | 230008357 | 1.63 | 73.1 | null | 2019-04-10 | 2019-05-07 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100750655 |
| 230002288 | 230008358 | 1.65 | 89.5 | null | null | 2020-10-12 | null | null | null | PEMBROLIZUMAB | 101757498 |
| 230002290 | 230008360 | 1.58 | 59 | null | 2020-07-21 | 2020-07-25 | ICON8B TRIAL | 02 | null | TRIAL UNSPECIFIED | 101378010 |
| 230002297 | 230008363 | null | null | Curative (C) | 2021-07-02 | 2021-07-14 | null | null | N | CVP R | 100462192 |
| 230002301 | 230008364 | 1.6 | 55 | Palliative (P) | null | 2018-10-06 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101230651 |
| 230002306 | 230008365 | 1.56 | 62.5 | null | null | 2020-01-26 | Paclitaxel 7 day | 02 | null | PACLITAXEL | 100902029 |
| 230002307 | 230008366 | 1.6 | 93.8 | Palliative (P) | 2017-07-12 | 2020-10-11 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 101679970 |
| 230002309 | 230008367 | 1.63 | 59 | Neo-adjuvant (N) | 2021-06-30 | 2021-08-05 | null | 2 | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101810486 |
| 230002313 | 230008369 | 1.62 | 93.8 | null | 2022-01-17 | 2022-02-10 | Liposomal Doxorubicin 40mg/m2 | 02 | null | LIPOSOMAL DOXORUBICIN | 101541704 |
| 230002315 | 230008370 | 1.62 | null | null | 2021-10-28 | 2021-12-11 | null | null | null | PEMBROLIZUMAB | 100647048 |
| 230002317 | 230008371 | 1.62 | 74.5 | Palliative (P) | 2019-10-22 | 2020-09-26 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100016451 |
| 230002318 | 230008372 | 1.58 | 66 | Adjuvant (A) | 2019-06-21 | 2019-06-26 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100267737 |
| 230002320 | 230008374 | 1.6 | 55.6 | null | null | 2019-08-10 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100190247 |
| 230002321 | 230008375 | 1.62 | 85.6 | Palliative (P) | 2018-09-07 | 2020-12-03 | null | null | N | OLAPARIB | 100046257 |
| 230002322 | 230008376 | 1.61 | 55 | Palliative (P) | 2016-12-09 | 2016-12-14 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100733512 |
| 230002325 | 230008377 | 1.71 | 91.65 | null | 2020-12-19 | 2020-12-20 | Niraparib | 02 | null | NIRAPARIB | 101826407 |
| 230002330 | 230008380 | 1.64 | 58.7 | null | null | 2021-09-02 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100776643 |
| 230002331 | 230008381 | 1.55 | 83 | null | 2016-10-16 | 2016-10-27 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101729418 |
| 230002333 | 230008382 | 1.68 | 40.3 | null | null | 2021-12-13 | null | null | null | BEVACIZUMAB | 100276629 |